News Hub: JPMorgan Chase & Co. (NYSE:JPM), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), SYNNEX Corp. (NYSE:SNX)

JPMorgan Chase & Co. (NYSE:JPM) slightly up on Friday in mid trading session is in talks with the U.S Securities and Exchange Commission to settle a probe into whether the bank inappropriately steered private-banking clients to its own investment products, the Wall Street Journal reported citing people familiar with the matter. The Journal reported that the regulator has been examining whether J.P. Morgan directed clients to its own so-called proprietary products and away from those offered by other firms. JPMorgan Chase & Co. (NYSE:JPM) stock price closed at $68.65 with the total traded volume of 13.31 Million shares. Its price to sales ratio ended at 4.97. Its market capitalization is 256.48 Billion. The stock owned by the Financial Institutions was 75.40% while by insiders was 0.20%.

Canadian drugmaker, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has made a preliminary move toward to purchase animal-health firm Zoetis Inc. (ZTS), according to the Wall Street Journal, quoting people familiar with the matter. It is not clear what the company’s reaction to the approach was, if any, or whether it is open to a sale, the Journal said. Zoetis, which makes medicines and vaccines for livestock and pet animals, was spun off from Pfizer, Inc. (PFE) in 2013. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) begun last trade with a price of $229.50 and throughout the trading session climbed at a high of $231.69. The day-trade ended with 1.75% to $233.21.

Business services provider, SYNNEX Corp. (NYSE:SNX) released that a increase in profit for the Q2, reflecting strong operating profit growth across all business segments. Earnings for the quarter dropped Wall Street anticipations, other than revenues dropped short of estimates. Moving ahead, the company provided a weak outlook for the third quarter, sending its shares down by about 9 percent in extended trade on the New York Stock Exchange. Fremont, California-based Synnex said its second-quarter profit rose to $51.9 million or $1.30 per share from $39.6 million or $1.00 per share last year. Commenting on the results, CEO Kevin Murai said, “I am pleased to report a record operating profit and margin for our second quarter. SYNNEX Corp. (NYSE:SNX) has the market capitalization of 2.95 Billion. Shares of firm plunged -1.12% to close at $82.34 with the total traded volume of 313184. The firm has current ratio of 1.60 for the most recent quarter.